170 Followers on Owler

Seres Therapeutics

is a Massachusetts-based biotechnology company that researches and develops novel microbiome therapeutics for the treatment of bacterial infections... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights

Seres Therapeutics

is a Massachusetts-based biotechnology company that researches and develops novel microbiome therapeutics for the treatment of bacterial infections... Read more
Seres Therapeutics Interim-CEO: Richard N. Kender

Interim-CEO

Richard N. Kender

CEO Approval Rating

82/100

2010

PublicNASDAQMCRB

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$1.9M
Employees
330
Funding
$617.9M
Investments
1

News

Conference Presentation
Sep 01, 2026
GlobeNewswire
Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Leadership Change
Mar 03, 2026
GlobeNewswire
Richard N. Kender joined Seres Therapeutics as Interim-CEO

Seres Therapeutics Competitors

1Vedanta
2Ferring Pharmaceuticals
3Armata
4Venatorx
5Morphochem
6Nuventra
7Xenon
8Anoixis
9Epic Sciences
10Voyager
Unlock 14 + competitors

Trending Companies